135 related articles for article (PubMed ID: 23316653)
1. [Retinal laser photocoagulation for familial transthyretin-related ocular amyloidosis].
Kawaji T
Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1046-51. PubMed ID: 23316653
[TBL] [Abstract][Full Text] [Related]
2. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation.
Kawaji T; Ando Y; Hara R; Tanihara H
Ophthalmology; 2010 Mar; 117(3):552-5. PubMed ID: 20045573
[TBL] [Abstract][Full Text] [Related]
3. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
[TBL] [Abstract][Full Text] [Related]
4. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
5. [Ocular involvement in familial amyloid polyneuropathy].
Rousseau A; Kaswin G; Adams D; Cauquil C; Théaudin M; Mincheva Z; M'garrech M; Labetoulle M; Barreau E
J Fr Ophtalmol; 2013 Nov; 36(9):779-88. PubMed ID: 24144522
[TBL] [Abstract][Full Text] [Related]
6. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.
Hara R; Kawaji T; Ando E; Ohya Y; Ando Y; Tanihara H
Arch Ophthalmol; 2010 Feb; 128(2):206-10. PubMed ID: 20142544
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin-related vitreous amyloidosis in different endemic areas.
Kawaji T; Ando Y; Ando E; Sandgren O; Suhr OB; Tanihara H
Amyloid; 2010 Sep; 17(3-4):105-8. PubMed ID: 21077797
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining images of vitreous transthyretin amyloid.
Latasiewicz M; Adan A; Solé M
Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
10. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
[TBL] [Abstract][Full Text] [Related]
11. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
12. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
[TBL] [Abstract][Full Text] [Related]
13. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
14. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
15. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.
Ohya Y; Okamoto S; Tasaki M; Ueda M; Jono H; Obayashi K; Takeda K; Okajima H; Asonuma K; Hara R; Tanihara H; Ando Y; Inomata Y
Surg Today; 2011 Sep; 41(9):1211-8. PubMed ID: 21874417
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation and transthyretin amyloidosis.
Benson MD
Muscle Nerve; 2013 Feb; 47(2):157-62. PubMed ID: 23169427
[TBL] [Abstract][Full Text] [Related]
17. [Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
Yamashita T
Brain Nerve; 2014 Jul; 66(7):763-71. PubMed ID: 24998821
[TBL] [Abstract][Full Text] [Related]
18. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy.
Sandgren O; Kjellgren D; Suhr OB
Acta Ophthalmol; 2008 Aug; 86(5):520-4. PubMed ID: 18435819
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
[TBL] [Abstract][Full Text] [Related]
20. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
